Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene

Amy H. Lin, Yanzheng Liu, Cynthia Burrascano, Kathrina Cunanan, Christopher R. Logg, Joan M. Robbins, Noriyuki Kasahara, Harry Gruber, Carlos Ibañez, Douglas J. Jolly

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We have developed retroviral replicating vectors (RRV) derived from Moloney murine gammaretrovirus with an amphotropic envelope and an encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES)-transgene cassette downstream of the env gene. During long-term (180 days) replication of the vector in animals, a bulge of 7 adenosine residues (A's) in the J-K bifurcation domain sometimes serially added A's. Therefore, vectors with 4-12 A's in the A bulge in the J-K bifurcation domain were generated, and the impact of the variants on transgene protein expression, vector stability, and IRES sequence upon multiple infection cycles was assessed in RRV encoding yeast-derived cytosine deaminase and green fluorescent protein in vitro. For transgene protein expression, after multiple infection cycles, RRV-IRES with 5-7 A's gave roughly comparable levels, 4 and 8 A's were within about 4-5-fold of the 6 A's, whereas 10 and 12 A's were marked lower. In terms of stability, after 10 infection cycles, expansion of A's appeared to be a more frequent event affecting transgene protein expression than viral genome deletions or rearrangement: 4 and 5 A's appeared completely stable; 6, 7, and particularly 8 A's showed some level of expansion in the A bulge; 10 and 12 A's underwent both expansion and transgene deletion. The strong relative translational activity of the 5 A's in the EMCV IRES has not been reported previously. The 5A RRV-IRES may have utility for preclinical and clinical applications where extended replication is required.

Original languageEnglish (US)
Pages (from-to)59-70
Number of pages12
JournalHuman gene therapy methods
Volume27
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Encephalomyocarditis virus
Transgenes
Gammaretrovirus
Infection
Cytosine Deaminase
env Genes
Proteins
Viral Genome
Green Fluorescent Proteins
Adenosine
Yeasts
Internal Ribosome Entry Sites

ASJC Scopus subject areas

  • Molecular Medicine
  • Applied Microbiology and Biotechnology
  • Genetics(clinical)
  • Genetics
  • Pharmacology

Cite this

Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene. / Lin, Amy H.; Liu, Yanzheng; Burrascano, Cynthia; Cunanan, Kathrina; Logg, Christopher R.; Robbins, Joan M.; Kasahara, Noriyuki; Gruber, Harry; Ibañez, Carlos; Jolly, Douglas J.

In: Human gene therapy methods, Vol. 27, No. 2, 01.04.2016, p. 59-70.

Research output: Contribution to journalArticle

Lin, Amy H. ; Liu, Yanzheng ; Burrascano, Cynthia ; Cunanan, Kathrina ; Logg, Christopher R. ; Robbins, Joan M. ; Kasahara, Noriyuki ; Gruber, Harry ; Ibañez, Carlos ; Jolly, Douglas J. / Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene. In: Human gene therapy methods. 2016 ; Vol. 27, No. 2. pp. 59-70.
@article{52548dcea31e4deea8f758c26737b3cb,
title = "Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene",
abstract = "We have developed retroviral replicating vectors (RRV) derived from Moloney murine gammaretrovirus with an amphotropic envelope and an encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES)-transgene cassette downstream of the env gene. During long-term (180 days) replication of the vector in animals, a bulge of 7 adenosine residues (A's) in the J-K bifurcation domain sometimes serially added A's. Therefore, vectors with 4-12 A's in the A bulge in the J-K bifurcation domain were generated, and the impact of the variants on transgene protein expression, vector stability, and IRES sequence upon multiple infection cycles was assessed in RRV encoding yeast-derived cytosine deaminase and green fluorescent protein in vitro. For transgene protein expression, after multiple infection cycles, RRV-IRES with 5-7 A's gave roughly comparable levels, 4 and 8 A's were within about 4-5-fold of the 6 A's, whereas 10 and 12 A's were marked lower. In terms of stability, after 10 infection cycles, expansion of A's appeared to be a more frequent event affecting transgene protein expression than viral genome deletions or rearrangement: 4 and 5 A's appeared completely stable; 6, 7, and particularly 8 A's showed some level of expansion in the A bulge; 10 and 12 A's underwent both expansion and transgene deletion. The strong relative translational activity of the 5 A's in the EMCV IRES has not been reported previously. The 5A RRV-IRES may have utility for preclinical and clinical applications where extended replication is required.",
author = "Lin, {Amy H.} and Yanzheng Liu and Cynthia Burrascano and Kathrina Cunanan and Logg, {Christopher R.} and Robbins, {Joan M.} and Noriyuki Kasahara and Harry Gruber and Carlos Iba{\~n}ez and Jolly, {Douglas J.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1089/hgtb.2015.131",
language = "English (US)",
volume = "27",
pages = "59--70",
journal = "Human gene therapy methods",
issn = "1946-6536",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene

AU - Lin, Amy H.

AU - Liu, Yanzheng

AU - Burrascano, Cynthia

AU - Cunanan, Kathrina

AU - Logg, Christopher R.

AU - Robbins, Joan M.

AU - Kasahara, Noriyuki

AU - Gruber, Harry

AU - Ibañez, Carlos

AU - Jolly, Douglas J.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - We have developed retroviral replicating vectors (RRV) derived from Moloney murine gammaretrovirus with an amphotropic envelope and an encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES)-transgene cassette downstream of the env gene. During long-term (180 days) replication of the vector in animals, a bulge of 7 adenosine residues (A's) in the J-K bifurcation domain sometimes serially added A's. Therefore, vectors with 4-12 A's in the A bulge in the J-K bifurcation domain were generated, and the impact of the variants on transgene protein expression, vector stability, and IRES sequence upon multiple infection cycles was assessed in RRV encoding yeast-derived cytosine deaminase and green fluorescent protein in vitro. For transgene protein expression, after multiple infection cycles, RRV-IRES with 5-7 A's gave roughly comparable levels, 4 and 8 A's were within about 4-5-fold of the 6 A's, whereas 10 and 12 A's were marked lower. In terms of stability, after 10 infection cycles, expansion of A's appeared to be a more frequent event affecting transgene protein expression than viral genome deletions or rearrangement: 4 and 5 A's appeared completely stable; 6, 7, and particularly 8 A's showed some level of expansion in the A bulge; 10 and 12 A's underwent both expansion and transgene deletion. The strong relative translational activity of the 5 A's in the EMCV IRES has not been reported previously. The 5A RRV-IRES may have utility for preclinical and clinical applications where extended replication is required.

AB - We have developed retroviral replicating vectors (RRV) derived from Moloney murine gammaretrovirus with an amphotropic envelope and an encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES)-transgene cassette downstream of the env gene. During long-term (180 days) replication of the vector in animals, a bulge of 7 adenosine residues (A's) in the J-K bifurcation domain sometimes serially added A's. Therefore, vectors with 4-12 A's in the A bulge in the J-K bifurcation domain were generated, and the impact of the variants on transgene protein expression, vector stability, and IRES sequence upon multiple infection cycles was assessed in RRV encoding yeast-derived cytosine deaminase and green fluorescent protein in vitro. For transgene protein expression, after multiple infection cycles, RRV-IRES with 5-7 A's gave roughly comparable levels, 4 and 8 A's were within about 4-5-fold of the 6 A's, whereas 10 and 12 A's were marked lower. In terms of stability, after 10 infection cycles, expansion of A's appeared to be a more frequent event affecting transgene protein expression than viral genome deletions or rearrangement: 4 and 5 A's appeared completely stable; 6, 7, and particularly 8 A's showed some level of expansion in the A bulge; 10 and 12 A's underwent both expansion and transgene deletion. The strong relative translational activity of the 5 A's in the EMCV IRES has not been reported previously. The 5A RRV-IRES may have utility for preclinical and clinical applications where extended replication is required.

UR - http://www.scopus.com/inward/record.url?scp=84964861725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964861725&partnerID=8YFLogxK

U2 - 10.1089/hgtb.2015.131

DO - 10.1089/hgtb.2015.131

M3 - Article

C2 - 26918465

AN - SCOPUS:84964861725

VL - 27

SP - 59

EP - 70

JO - Human gene therapy methods

JF - Human gene therapy methods

SN - 1946-6536

IS - 2

ER -